Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
TIGIT Inhibitors - Competitive Landscape, 2022
... type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage TIGIT inhibitors: Understanding TIGIT inhibitors: Overview T-cell immunoreceptor with Ig and ITIM ... Read More
-
Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Others); By Diagnosis; By Cancer Type, By End-Users; By Region; Segment Forecast, 2022 - 2030
... global pancreatic cancer market size is expected to reach USD 7.04 million by 2030, according to a new study by Polaris Market Research. The report “Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By ... Read More
-
RNA- Competitive Landscape, 2022
... and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage RNA: Understanding RNA: Overview RNA interference (RNAi) is one of the pathways, collectively named RNA silencing pathways ... Read More
-
Janus kinase (JAK) Inhibitors- Competitive Landscape, 2022
... therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Janus kinase (JAK) inhibitors: Understanding Janus kinase (JAK) ... Read More
-
PD-1 and PD-L1 Inhibitors- Competitive Landscape, 2022
... therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage PD-1 AND PD-L1 Inhibitors: Understanding PD-1 AND PD-L1 ... Read More
-
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape. Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of ... Read More
-
Glycoprotein 41 (gp41) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... are developed by companies and remaining by the universities/institutes. The latest report Glycoprotein 41 - Drugs In Development, 2022, outlays comprehensive information on the Glycoprotein 41 (gp41) targeted therapeutics, complete with analysis by indications, stage ... Read More
-
20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... the ubiquitin pathway of protein degradation. It is commonly associated with regulatory complexes, which include the 19S Proteasome, the PA28 alpha/beta complex, or the PA28 gamma complex. The 20S Proteasome is composed of 28 subunits ... Read More
-
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... published report 'C-C Chemokine Receptor Type 5 - Drugs In Development, 2022'; C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 16 molecules. Out ... Read More
-
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... a transport protein. It transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, ... Read More
-
Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... In Development, 2022'; Glucagon Like Peptide 2 Receptor (GLP2R) pipeline Target constitutes close to 18 molecules. Out of which approximately 17 molecules are developed by companies and remaining by the universities/institutes. Glucagon Like Peptide 2 ... Read More
-
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Glycogen synthase kinase 3 beta also known as GSK3B is an enzyme encoded by the GSK3B. It constitutively activate ... Read More
-
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Kinase C Epsilon Type - Drugs In Development, 2022'; Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) pipeline Target constitutes close to 11 molecules. Out of which approximately 11 molecules are ... Read More
-
Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022'; Catenin Beta 1 (Beta Catenin or CTNNB1) pipeline Target constitutes close to 23 molecules. Out of which approximately 17 molecules are developed by companies and remaining by the universities/institutes. Catenin Beta 1 (Beta ... Read More
-
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... or EC 2.7.1.2) pipeline Target constitutes close to 21 molecules. Out of which approximately 19 molecules are developed by companies and remaining by the universities/institutes. The latest report Glucokinase - Drugs In Development, 2022, outlays ... Read More
-
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) pipeline Target constitutes close to 45 molecules. Out of which approximately 41 molecules are developed by companies and remaining by the universities/institutes. The latest ... Read More
-
C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... close to 11 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report C5a Anaphylatoxin Chemotactic Receptor 1 - Drugs In Development, 2022, outlays comprehensive information ... Read More
-
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... PTGER4) - Prostaglandin E2 receptor 4 (EP4) is a prostaglandin receptor encoded by the PTGER4 gene. The activity of the receptor is mediated by G proteins that stimulate adenylate cyclase. It has a relaxing effect ... Read More
-
Global Artificial Intelligence (AI) in Healthcare Market Size study, by Offering (Hardware, software, Services) by Technology (Machine learning, Natural Language Processing, Context-aware Computing, Computer Vision), by Application (Patient Data & Risk Analysis, Inpatient Care & Hospital Management, Medical Imaging & Diagnostics, Lifestyle Management & Monitoring, Virtual Assistants, Drug Discovery, Research, Healthcare Assistant Robots, Precision Medicine, Emergency Room & Surgery, Wearables, Mental Health, Cybersecurity), By End User (Hospital & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers, Others) and Regional Forecasts 2022-2028
... Hospital Management, Medical Imaging & Diagnostics, Lifestyle Management & Monitoring, Virtual Assistants, Drug Discovery, Research, Healthcare Assistant Robots, Precision Medicine, Emergency Room & Surgery, Wearables, Mental Health, Cybersecurity), By End User (Hospital & Healthcare Providers, ... Read More
-
Global MicroRNA Market - 2022-2029
... during the forecast period (2022-2029). MicroRNAs (or miRNAs) are a new class of tiny, non-coding endogenous RNAs that control gene expression by targeting mRNAs for destruction or translational suppression. Their discovery expanded the understanding of ... Read More
-
Global Human Liver Models Market - 2022-2029
... of XX % during the forecast period (2022-2029). The human liver model is a structure used to research the drug's potential for liver failure and other liver diseases. It allows for the improvement of knowledge ... Read More
-
Live Cell Imaging Market - Global Outlook & Forecast Market 2022-2027
... of the popular techniques for studying live cells and investigating the biological processes in real-time. It utilizes time-lapse microscopy and careful preparation of living cell environments that have made it easier to observe cell-to-cell interactions ... Read More
-
Cell Culture Market, by Product Type (Instruments and Consumables), by Application (Vaccine Production, Gene Therapy, Cancer Research, Tissue Culture, Drug Development, and Others), by End User (Academic & Research Institutions, and Pharmaceutical and Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The technique of growing cells outside the human body itself is a ... Read More
-
Cytokine Market, By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF, and Other Cytokine Types), By Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis, and Other Therapeutic Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cytokines are a category of small proteins important in cell signaling. They are small proteins that ... Read More
-
Biopreservation Market Size By Product (Equipment {Freezers, Refrigerators, Consumables [Vials, Straws, Microtiter, Bags], Liquid Nitrogen}, Media {Pre-formulated, Home-brew}, Laboratory Information Management System [LIMS]), By Application (Regenerative Medicine {Cell Therapy, Gene Therapy}, Biobanking {Human Eggs, Human Sperm, Veterinary IVF}, Drug Discovery), By Cell Provider (CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells), Industry Analysis Report, Regional Outlook Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Sperm, Veterinary IVF}, Drug Discovery), By Cell Provider (CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells), Industry Analysis Report, Regional Outlook Growth Potential, Competitive Market Share & Forecast, 2022 - 2030 The biopreservation market is slated ... Read More
Research Assistance
